Safe and Green Development (SGD) is excited to share its expected timeline for completion of its joint venture developments in Southern Texas. The timeline below is only considering the existing ...
DALLAS--(BUSINESS WIRE)-- Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology ...
The US military takes too long to develop new technologies and turn them into effective battlefield platforms. That is the assessment of Deputy Secretary of Defense Kathleen Hicks, who on 31 August ...
A veteran processor architect striving to regain its glory in the RISC-V architecture arena.MIPSMIPS has been making frequent moves recently. It announced that it will accelerate its designs for edge ...
The invention, rapid manufacturing and distribution of the COVID-19 vaccine demonstrates exactly how fast the life sciences treatment development pipeline can move when the right factors are in play.
Cambridge, MA – Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks ...
A key part of consultants’ work is the global harmonization of CMC guidelines. Differences in regulatory requirements across regions can lead to inefficiencies in the drug development process.
Global harmonization of CMC guidelines is a key focus for top pharmaceutical consultants. Variations in regulatory requirements across regions often create inefficiencies in drug development—for ...
The pharmaceutical industry invests heavily in technologies—$57.4 billion in 2022 alone—to discover new therapies to treat our greatest health challenges. Yet drug development teams are still using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results